Ascentage Pharma Group International

SEHK:6855 Stok Raporu

Piyasa değeri: HK$12.7b

Ascentage Pharma Group International Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Ascentage Pharma Group International yıllık ortalama 10.4% oranında kazançlarını artırırken, Biotechs sektöründe kazançlar growing at 31.7% annual. Gelirler yılda ortalama 73.2% oranında büyüyor .

Anahtar bilgiler

10.4%

Kazanç büyüme oranı

29.5%

EPS büyüme oranı

Biotechs Sektör Büyümesi11.0%
Gelir büyüme oranı73.2%
Özkaynak getirisi-46.4%
Net Marj-39.9%
Son Kazanç Güncellemesi30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Ascentage Pharma Group International's (HKG:6855) Shares Climb 26% But Its Business Is Yet to Catch Up

Sep 04
Ascentage Pharma Group International's (HKG:6855) Shares Climb 26% But Its Business Is Yet to Catch Up

Here's Why Ascentage Pharma Group International (HKG:6855) Can Afford Some Debt

Aug 26
Here's Why Ascentage Pharma Group International (HKG:6855) Can Afford Some Debt

Ascentage Pharma Group International's (HKG:6855) Shares Climb 29% But Its Business Is Yet to Catch Up

Jun 18
Ascentage Pharma Group International's (HKG:6855) Shares Climb 29% But Its Business Is Yet to Catch Up

Here's Why Ascentage Pharma Group International's (HKG:6855) CEO May Not Expect A Pay Rise This Year

May 03
Here's Why Ascentage Pharma Group International's (HKG:6855) CEO May Not Expect A Pay Rise This Year

Why We're Not Concerned Yet About Ascentage Pharma Group International's (HKG:6855) 30% Share Price Plunge

Mar 30
Why We're Not Concerned Yet About Ascentage Pharma Group International's (HKG:6855) 30% Share Price Plunge

Are Investors Undervaluing Ascentage Pharma Group International (HKG:6855) By 40%?

Feb 17
Are Investors Undervaluing Ascentage Pharma Group International (HKG:6855) By 40%?

There's Reason For Concern Over Ascentage Pharma Group International's (HKG:6855) Price

Dec 20
There's Reason For Concern Over Ascentage Pharma Group International's (HKG:6855) Price

Ascentage Pharma Group International (HKG:6855) Is Making Moderate Use Of Debt

Oct 28
Ascentage Pharma Group International (HKG:6855) Is Making Moderate Use Of Debt

Some Analysts Just Cut Their Ascentage Pharma Group International (HKG:6855) Estimates

Aug 27
Some Analysts Just Cut Their Ascentage Pharma Group International (HKG:6855) Estimates

There's Reason For Concern Over Ascentage Pharma Group International's (HKG:6855) Price

Aug 23
There's Reason For Concern Over Ascentage Pharma Group International's (HKG:6855) Price

Ascentage Pharma Group International (HKG:6855) Is Carrying A Fair Bit Of Debt

Jun 19
Ascentage Pharma Group International (HKG:6855) Is Carrying A Fair Bit Of Debt

Ascentage Pharma Group International (HKG:6855) Has Debt But No Earnings; Should You Worry?

Dec 04
Ascentage Pharma Group International (HKG:6855) Has Debt But No Earnings; Should You Worry?

Is Ascentage Pharma Group International (HKG:6855) A Risky Investment?

Aug 30
Is Ascentage Pharma Group International (HKG:6855) A Risky Investment?

Does Ascentage Pharma Group International (HKG:6855) Have A Healthy Balance Sheet?

Oct 04
Does Ascentage Pharma Group International (HKG:6855) Have A Healthy Balance Sheet?

Gelir ve Gider Dağılımı

Ascentage Pharma Group International nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SEHK:6855 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Jun 24903-360378841
31 Mar 24563-643377774
31 Dec 23222-926376707
30 Sep 23239-902363709
30 Jun 23257-879349712
31 Mar 23233-881339727
31 Dec 22210-883328743
30 Sep 22160-848299767
30 Jun 22111-812270790
31 Mar 2269-797231778
31 Dec 2128-782191766
30 Sep 2125-759167699
30 Jun 2123-735143631
31 Mar 2118-706137598
31 Dec 2012-678130565
30 Sep 2014-922146540
30 Jun 2015-1,167162516
31 Mar 2015-1,324162490
31 Dec 1915-1,481162464
30 Sep 1911-1,171133418
30 Jun 197-862104372
31 Mar 197-60497311
31 Dec 187-34590250
31 Dec 176-11926119
31 Dec 168-10822103

Kaliteli Kazançlar: 6855 şu anda kârlı değil.

Büyüyen Kar Marjı: 6855 şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 6855 kârlı değildir, ancak son 5 yılda zararlarını yılda 10.4% oranında azaltmıştır.

Büyüme Hızlandırma: 6855 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: 6855 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Biotechs sektörüyle ( 4% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: 6855 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -46.43% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin